FedEx Embroiled in Illegal Internet Pharmacy Scandal
Shareholder and consumer rights law firm Schubert Jonckheer & Kolbe LLP launched an investigation into whether certain officers and directors of FedEx Corporation (NYSE: FDX) breached their fiduciary duties to FedEx and its shareholders by exposing FedEx to potential criminal liability for allegedly conspiring to distribute controlled substances and prescription drugs for illegal Internet pharmacies.
In July 2014, FedEx Corporation was indicted by a federal grand jury in San Francisco, California for its alleged role in conspiracies to traffic in controlled substances and prescription drugs with an organization run by Vincent Chhabra and Robert Smoley (the “Smoley-Chhabra organization”) and Superior Drugs. The indictment alleges that FedEx employees knew that Internet pharmacies affiliated with both the Chhabra-Smoley organization and Superior Drugs had been closed down by state and federal law enforcement agencies and that their owners, operators, pharmacies, and doctors had been indicted, arrested and convicted of illegally distributing drugs. Yet, according to the indictment, FedEx continued to deliver controlled substances and prescription drugs for the Chhabra-Smoley organization and Superior Drugs.
An indictment merely alleges that crimes have been committed, and all defendants are presumed innocent unless and until proven guilty beyond a reasonable doubt.
The Schubert Law Firm's investigation concerns the extent to which certain FedEx officers and directors knew or should have known of the facts alleged in the indictment, before the grand jury actually indicted FedEx, and any actions they took related to FedEx’s alleged role in the conspiracy. The investigation also concerns FedEx officers’ and directors’ knowledge regarding the investigations conducted by various government agencies, including the Department of Justice and the Drug Enforcement Agency, into FedEx’s alleged conspiracy.
If you currently own FedEx stock and wish to obtain additional information about the investigation and your legal rights, please fill out our form (at right) or contact Miranda Kolbe either via email at email@example.com or by phone at 415-788-4220.